Who owns Recro Pharma?
- Ticker: SCTL
- CUSIP Number: 75629f109
Tip: Access positions for across all investors
Analyze quarterly positions in Recro Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Recro Pharma stock
Who bought or sold Recro Pharma this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| First Light Asset Management | 20M | $6.9M | 0% | Dec 2023 |
|
| AWM Investment Company | 7.2M | $2.5M | -30% | Dec 2023 |
|
| Royce & Associates | 3.3M | $1.2M | 0% | Dec 2023 |
|
| Samjo Management | 3.1M | $1.1M | 100% | Dec 2023 |
|
| Vanguard Group | 3.1M | $1.1M | 0% | Dec 2023 |
|
| OV Management | 3.0M | $1.0M | 100% | Dec 2023 |
|
| Caligan Partners | 1.7M | $592k | 0% | Dec 2023 |
|
| First Eagle Investment Management | 1.6M | $572k | 0% | Dec 2023 |
|
| Alyeska Investment Group | 1.6M | $560k | 0% | Dec 2023 |
|
| Nantahala Capital Management | 1.2M | $426k | -3% | Dec 2023 |
|
| HighMark Wealth Management | 485k | $170k | 0% | Dec 2023 |
|
| Clear Harbor Asset Management | 359k | $126k | -62% | Dec 2023 |
|
| Titleist Asset Management | 206k | $72k | -2% | Dec 2023 |
|
| Citadel Advisors | 159k | $56k | 128% | Dec 2023 |
|
| Millennium Management | 98k | $35k | 635% | Dec 2023 |
|
| Global Retirement Partners | 56k | $20k | 273% | Dec 2023 |
|
| Bank of New York Mellon | 56k | $20k | 0% | Dec 2023 |
|
| Hrt Financial | 53k | $18k | 100% | Dec 2023 |
|
| Amplius Wealth Advisors | 48k | $52k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 37k | $13k | 0% | Dec 2023 |
|
| Bank of America Corporation | 32k | $11k | 0% | Dec 2023 |
|
| Wynnefield Capital | 13k | $4.6k | 0% | Dec 2023 |
|
| Commonwealth Equity Services | 12k | $4.0k | 0% | Dec 2023 |
|
| Dimension Capital Management Partners | 11k | $3.7k | 0% | Dec 2023 |
|
| Sandy Spring Bank | 2.0k | $701.950800 | 0% | Dec 2023 |
|
| Wells Fargo & Company | 942.00 | $330.076800 | 22% | Dec 2023 |
|
| Capital Advisors | 557.00 | $999.982100 | 100% | Mar 2024 |
|
| Royal Bank of Canada | 354.00 | $0 | 7% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 257.00 | $90.001400 | 0% | Dec 2023 |
|
| Barclays | 113.00 | $0 | 100% | Dec 2023 |
|
Who sold out of Recro Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Kornitzer Capital Management | Sep 2023 | 350k | $164k |
| Hourglass Capital | Sep 2023 | 60k | $28k |
| Damian Sousa | Sep 2023 | 47k | $22k |
| Two Sigma Securities | Sep 2023 | 25k | $12k |
| Jane Street | Sep 2023 | 24k | $11k |
| Weaver Consulting Group | Dec 2023 | 20k | $7.0k |
| Virtu Financial | Sep 2023 | 13k | $6.0k |
| United Capital Financial Advisers | Sep 2023 | 12k | $5.6k |
| UBS Group | Sep 2023 | 8.2k | $3.8k |